Influence of hypoxic therapy on the content of individual cytokines in women with autoimmune thyroiditis

Abstract

Background. The high prevalence of autoimmune thyroiditis and the insufficient effectiveness of hormone replacement therapy dictate the need to explore alternative methods of treating the disease. These methods include interval hypoxic therapy, but its effect on the cytokine profile in autoimmune thyroiditis has not been studied enough.

Aim. To study the effect of interval hypoxic therapy in combination with hormone replacement therapy on cytokine status in autoimmune thyroiditis and hypothyroidism.

Material and methods. 136 women with primary diagnosed autoimmune thyroiditis and hypothyroidism were examined. Half of them (n=68) received only hormone replacement therapy for 12 months. The rest of the women (n=68), along with sodium levothyroxine, underwent sessions of interval hypoxic therapy (every 3 months for 10 days according to the formula 5–5–5). The concentrations of interleukins-4, -6, -8, -10 and tumor necrosis factor α in blood serum were determined. To compare the results in groups, Kruskal–Wallis rank univariate analysis and Dunn's test were used. The Wilcoxon t-test was used to compare two related samples.

Results. Both isolated hormone therapy and its combination with hypoxic therapy did not affect the concentrations of interleukins-4, -8, -10 and tumor necrosis factor α in the blood serum of women with initially diagnosed autoimmune thyroiditis and hypothyroidism. However, hypoxic therapy caused a decrease (p=0.0001) in the initially elevated concentration of interleukin-6 to the level of the control group, which did not happen with the isolated intake of levothyroxine sodium.

Conclusion. The combination of sodium levothyroxine with hypoxic therapy causes a decrease in the level of interleukin-6, which is elevated in women with newly diagnosed autoimmune thyroiditis and hypothyroidism.

Keywords

women / autoimmune thyroiditis / interval hypoxic therapy / cytokines

References

[1] Gryaznova MA, Khamnueva LYu. The specific feature of cytokines regulation by pathology of thyroid disease (review). Health & education millennium. 2017;19(7):33–39. (In Russ.)

[2] Грязнова М.А., Хамнуева Л.Ю. Особенности цитокиновой регуляции при аутоиммунной патологии щитовидной железы. Журнал научных статей «Здоровье и образование в XXI веке». 2017;19(7):33–39. EDN: XXYDBF.

[3] Rozhko VA. Current state of the autoimmune thyroiditis problem. Health and ecology issues. 2019;(2):4–13. (In Russ.)

[4] Рожко В.А. Современное состояние проблемы аутоиммунного тиреоидита. Проблемы здоровья и экологии. 2019;(2):4–13. EDN: ZBMLRM.

[5] Boldyreva YV, Lebedev IA, Kruchinin EV, Alekberov RI, Tarasov DO, Tyapkin AV, Kozlov MV, Akhmetianov MA, Lukashenok AV, Mokin EA, Fidomatova ZSh. A unified approach to patient management with autoimmune thyroiditis (literature review). Uralskiy me-ditsinskiy zhurnal. 2019;(7):110–113. (In Russ.) DOI: 10.25694/URMJ.2019.07.25.

[6] Болдырева Ю.В., Лебедев И.А., Кручинин Е.В., Алекберов Р.И., Тарасов Д.О., Тяпкин А.В., Козлов М.В., Ахметьянов М.А., Лукашенок А.В., Мокин Е.А., Фидоматова З.Ш. Единый подход к ведению пациентов с аутоиммунным тиреоидитом (литературный обзор). Уральский медицинский журнал. 2019;(7):110–113. DOI: 10.25694/URMJ.2019.07.25.

[7] Mincer DL, Jialal I. Hashimoto thyroiditis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. https://www.ncbi.nlm.nih.gov/books/NBK459262/ (access date: 16.03.2023).

[8] Shao S, Yu X, Shen L. Autoimmune thyroid diseases and Th17/Treg lymphocytes. Life Sci. 2018;192:160–165. DOI: 10.1016/j.lfs.2017.11.026.

[9] Ajjan RA, Weetman AP. Pathogenesis of Hashimoto’s thyroiditis: Further developments in our understanding. Horm Metab Res. 2015;47:702–710. DOI: 10.1055/s-0035-1548832.

[10] Order of the Ministry of Health of the Russian Federation No. 1205n dated 29.12.2021 “On approval of the standard of primary health care for adults with hypothyroidism (diagnosis and treatment)” (registered 04.02.2022 No. 67156). http://publication.pravo.gov.ru/Document/View/0001202202040036 (access date: 16.03.2023). (In Russ.)

[11] Приказ Министерства здравоохранения Российской Федерации от 29.12.2021 №1205н «Об утверждении стандарта первичной медико-санитарной помощи взрослым при гипотиреозе (диагностика и лечение)» (зарегистрирован 04.02.2022 №67156). http://publication.pravo.gov.ru/Document/View/0001202202040036 (дата обращения: 16.03.2023).

[12] Lee SA, Stetten NE, Anton SD. Patient perspectives on the treatment for Hashimoto’s thyroiditis: A qualitative analysis. Health Prim Car. 2018;2(4):1–5. DOI: 10.15761/HPC.1000141.

[13] Fadeyev VV. Challenges in replacement therapy of hypothyroidism: everyday practice and perspectives. Klinicheskaya i eksperimental'naya tireoidologiya. 2012;8(3):17–29. (In Russ.)

[14] Фадеев В.В. Проблемы заместительной терапии гипотиреоза: современность и перспективы. Клиническая и экспериментальная тиреоидология. 2012;8(3):17–29. EDN: QZGUVV.

[15] Borukaeva IKh, Abazova ZKh, Ragimbekova MR, Temirzhanova FKh. Effect of interval hypoxytherapy and entеral oxygenotherapy on immunological reactivity in patients with bronchal asthma. Russian Journal of Immunology. 2019;13(2–1):174–176. (In Russ.) DOI: 10.31857/S102872210006443-2.

[16] Борукаева И.Х., Абазова З.Х., Рагимбекова М.Р., Темиржанова Ф.Х. Влияние интервальной гипокситерапии и энтеральной оксигенотерапии на иммунологическую реактивность у больных бронхиальной астмой. Российский иммунологический журнал. 2019;13(2–1):174–176. DOI: 10.31857/S102872210006443-2.

[17] Park HY, Jung WS, Kim J, Hwang H, Lim K. Changes in the paradigm of traditional exercise in obesity therapy and application of a new exercise modality: A narrative review article. Iran J Public Health. 2019;48(8):1395–1404. DOI: 10.18502/ijph.v48i8.2978.

[18] Abazova ZKh, Borukaeva IKh. Hypoxic therapy in the correction of neuroimmunoendocrine disorders in autoimmune thyroiditis. Medical academic journal. 2019;19(1S):49–51. (In Russ.) DOI: 10.17816/MAJ191S149-51.

[19] Абазова З.Х., Борукаева И.Х. Гипокситерапия в коррекции нейроиммуноэндокринных нарушений при аутоиммунном тиреоидите. Медицинский академический журнал. 2019;19(1S):49–51. DOI: 10.17816/MAJ191S149-51.

[20] Radziejowska M. Efficiency of adaptation to hypoxic hypoxia in a course of artificial climatetherapy in correction of the hormonal status at thyroid gland hypofunction at children. Journal of Education, Health and Sport. 2018;8(10):347–356. DOI: 10.5281/zenodo.1501808.

[21] Tsyganova TN, Kulchitskaya DB, Konchygova TV. Efficiency of IHT use in the treatment of endocrine patho-logy. Journal of New Medical Technologies, eEdition. 2018;(5):179–184. (In Russ.) DOI: 10.24411/2075-4094-2018-16156.

[22] Цыганова Т.Н., Кульчицкая Д.Б., Кончугова Т.В. Эффективность использования нормобарической интервальной гипоксической тренировки в лечении эндокринной патологии. Вестник новых медицинских технологий. Электронное издание. 2018;(5):179–184. DOI: 10.24411/2075-4094-2018-16156.

[23] Borukaeva IKh, Abazova ZKh, Kumykov VK, Shibzukhova LA. Efficiency of hypoxic therapy at subclinical thyroid dysfunction with autoimmune genesis. Russian Journal of Immunology. 2019;22(2–1):124–126. (In Russ.) DOI: 10.31857/S102872210006423-0.

[24] Абазова З.Х., Борукаева И.Х., Кумыков В.К., Шибзухова Л.А. Эффективность гипокситерапии при субклинической тиреоидной дисфункции аутоиммунного генеза. Российский иммунологический журнал. 2019;22(2–1):124–126. DOI: 10.31857/S102872210006423-0.

[25] Abazova ZKh. Interval hypoxic training in the treatment of neuroimmunoendocrine disorders in autoimmune thyroiditis. Bulletin of rehabilitation medicine. 2013;(1):27–31. (In Russ.)

[26] Абазова З.Х. Интервальная гипоксическая тренировка в лечении нейроиммуноэндокринных нарушений при аутоиммунном тиреоидите. Вестник восстановительной медицины. 2013;(1):27–31. EDN: PYCBBB.

[27] Voronina T, Grechko N, Shikhlyarova AI, Bobkova N. Intermittent hypoxic training as an effective method of activation therapy. Cardiometry. 2017;10:93–99. DOI: 10.12710/cardiometry.2017.9399.

[28] Caris AV, Lira FS, de Mello MT, Oyama LM, dos Santos RV. Carbohydrate and glutamine supplementation modulates the Th1/Th2 balance after exercise performed at a simulated altitude of 4500 m. Nutrition. 2014;30(11–12):1331–1336. DOI: 10.1016/j.nut.2014.03.019.

[29] Gangwar A, Paul S, Ahmad Y, Bhargava K. Intermittent hypoxia modulates redox homeostasis, lipid metabolism associated inflammatory processes and redox post-translational modifications: Benefits at high altitude. Sci Rep. 2020;10(1):7899. DOI: 10.1038/s41598-020-64848-x.

[30] Wang JS, Chen WL, Weng TP. Hypoxic exercise training reduces senescent T-lymphocyte subsets in blood. Brain Behav Immun. 2011;25(2):270–278. DOI: 10.1016/j.bbi.2010.09.018.

RIGHTS & PERMISSIONS

Eco-Vector